EIX vs LXRX · P/E 7.3, rev $19.32B vs rev $21.8M
Edison International (EIX) versus Lexicon Pharmaceuticals Inc (LXRX) — a side-by-side from cached financials, not a winner call.
Edison International (EIX) is a utilities - regulated electric company listed on US.
Lexicon Pharmaceuticals Inc (LXRX) is a biotechnology company listed on US.
Latest reported EIX revenue for 2025-12-31 was $19.32B. Net income was $4.46B. Revenue was up 9.8% from 2024-12-31 to 2025-12-31. EIX currently screens at market cap $19.73B and trailing P/E 7.3.
Latest reported LXRX revenue for 2026-06-30 was $21.8M. Net income was -$32.8M. Revenue was up 3.3% from 2026-03-31 to 2026-06-30. LXRX currently screens at market cap $327.2M.
EIX currently screens at market cap $19.73B and trailing P/E 7.3. LXRX currently screens at market cap $327.2M.
Not investment advice. Open the EIX and LXRX stock pages for the full models.
Not investment advice.